Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections, Herpesviridae”

2,379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,379 results

Post-approval studies (Phase 4)Study completedNCT01817270
What this trial is testing

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Who this might be right for
Chickenpox
Changchun Keygen Biological Products Co., Ltd. 368
Testing effectiveness (Phase 2)Study completedNCT04165122
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Who this might be right for
Herpes Genitalis
Heidelberg ImmunoTherapeutics GmbH 122
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Early research (Phase 1)Study completedNCT01986010
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

Who this might be right for
Cytomegalovirus Infections
Merck Sharp & Dohme LLC 190
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT03699254
What this trial is testing

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

Who this might be right for
Transplantation InfectionCytomegalovirus Infections
Maimónides Biomedical Research Institute of Córdoba 150
Testing effectiveness (Phase 2)Study completedNCT04225923
What this trial is testing

Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Who this might be right for
Cytomegalovirus Disease
Nobelpharma 87
Not applicableStudy completedNCT00712556
What this trial is testing

PET Study in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 55
Early research (Phase 1)Active Not RecruitingNCT02992522
What this trial is testing

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Lymphoma, UnspecifiedGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+10 more
Beth Christian 22
Not applicableStudy completedNCT02902822
What this trial is testing

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Who this might be right for
ErysipelasImpetigoHerpes Zoster+7 more
Centro Studi Gised 461
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Early research (Phase 1)Ended earlyNCT00006222
What this trial is testing

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00006098
What this trial is testing

PS-341 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03469804
What this trial is testing

Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma

Who this might be right for
Kaposi SarcomaProgression, Disease
Assistance Publique - Hôpitaux de Paris 17
Early research (Phase 1)Study completedNCT01535885
What this trial is testing

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Who this might be right for
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Medical College of Wisconsin 25
Not applicableStudy completedNCT05597085
What this trial is testing

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Who this might be right for
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Pfizer 32
Testing effectiveness (Phase 2)Looking for participantsNCT07368634
What this trial is testing

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Epstein-Barr Virus InfectionPost-Transplant Lymphoproliferative Disorder
Daihong Liu 18
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Load More Results